Literature DB >> 7639629

Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings.

D L Sultzer1, M E Mahler, J L Cummings, W G Van Gorp, C H Hinkin, C Brown.   

Abstract

OBJECTIVE: To examine the effects of subcortical lesions on cortical metabolic rate and clinical symptoms in patients with vascular dementia.
METHOD: Eleven elderly patients with vascular dementia who demonstrated no lesion involving the cerebral cortex on magnetic resonance imaging underwent 18F-fluorodeoxyglucose positron emission tomography to assess global cortical metabolism and metabolic activity in each cortical lobe. Subcortical lesions on magnetic resonance imaging (periventricular hyperintensities, deep white matter hyperintensities, and subcortical lacunar infarcts) were measured using a graded scale of severity. Cognitive and noncognitive symptoms were assessed with the Neurobehavioral Rating Scale.
RESULTS: Reduced cortical metabolism was generally associated with the severity of subcortical pathologic changes, but there was substantial heterogeneity in the relationship between subcortical lesions and cortical metabolic activity. Mean global cortical metabolism was lower in patients with periventricular hyperintensities in anterior subcortical regions than in those without such lesions. The metabolic rate in the frontal cortex was lower in patients with a lacunar infarct of the basal ganglia or thalamus than in those without. Neurobehavioral Rating Scale total score, the Verbal Output Disturbance factor score, and the Anxiety/Depression factor score were correlated with the severity of white matter lesions.
CONCLUSIONS: Cortical metabolic dysfunction is related to ischemic subcortical lesions in patients with vascular dementia. Metabolism in the frontal cortex may be particularly dependent on pathologic alterations of subcortical nuclei. Anxiety, depression, and the overall severity of neuropsychiatric symptoms in vascular dementia are associated with the extent of white matter ischemia.

Entities:  

Mesh:

Year:  1995        PMID: 7639629     DOI: 10.1001/archneur.1995.00540320049012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  28 in total

Review 1.  The neuropsychiatry of subcortical ischemic brain disease.

Authors:  D Feil; A Kumar
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  The neurobehavioural rating scale-revised: sensitivity and validity in closed head injury assessment.

Authors:  S R McCauley; H S Levin; M Vanier; J M Mazaux; C Boake; P R Goldfader; D Rockers; M Butters; D A Kareken; J Lambert; G L Clifton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

3.  Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease.

Authors:  S E Starkstein; L Sabe; S Vázquez; G Di Lorenzo; A Martínez; G Petracca; A Tesón; E Chemerinski; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

4.  Vascular Cognitive Impairment.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

Review 5.  Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.

Authors:  Peter J Nestor; Daniele Altomare; Cristina Festari; Alexander Drzezga; Jasmine Rivolta; Zuzana Walker; Femke Bouwman; Stefania Orini; Ian Law; Federica Agosta; Javier Arbizu; Marina Boccardi; Flavio Nobili; Giovanni Battista Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-07       Impact factor: 9.236

Review 6.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Revamping neurorehabilitation in Oman.

Authors:  S Al-Adawi; D T Burke
Journal:  J Sci Res Med Sci       Date:  2001-10

Review 8.  Molecular neuroimaging in Alzheimer's disease.

Authors:  William Jagust
Journal:  NeuroRx       Date:  2004-04

9.  White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies.

Authors:  Poornima Venkat; Michael Chopp; Alex Zacharek; Chengcheng Cui; Li Zhang; Qingjiang Li; Mei Lu; Talan Zhang; Amy Liu; Jieli Chen
Journal:  Neurobiol Aging       Date:  2016-11-19       Impact factor: 4.673

10.  White matter lesions impair frontal lobe function regardless of their location.

Authors:  M Tullberg; E Fletcher; C DeCarli; D Mungas; B R Reed; D J Harvey; M W Weiner; H C Chui; W J Jagust
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.